MDWD

Healthcare Biotechnology

MediWound Ltd.

$13.52

-0.08 -0.59% today

Price History

Not enough data

Key Stats

Market Cap

174.55M

Avg Volume

85,765

EPS

-$2.16

52W High

$20.03

52W Low

$12.52

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-5.90

P/B Ratio

4.90

P/S Ratio

14.71

EV/EBITDA

-4.81

EV/Revenue

12.46

Margins

Gross Margin 15.5%

Operating Margin (305.9%)

Net Margin (170.1%)

EBITDA Margin (259.2%)

Growth & Returns

Revenue Growth (YoY)

(45.8%)

Return on Equity

(72.4%)

Return on Assets

(28.6%)

Liquidity & Leverage

Current Ratio

2.32

Quick Ratio

2.09

Debt / Equity

0.24

Total Cash

35.34M

Total Debt

8.61M

About

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.